Valion Bio (VBIO) Asset Writedowns and Impairment (2021 - 2024)
Valion Bio (VBIO) recorded Asset Writedowns and Impairment of $338,000 in Q4 2024.
Powered by 
Analysis
Valion Bio (VBIO) Asset Writedowns and Impairment (2021 - 2024) Analysis & Trends
For FY2024, Valion Bio reported Asset Writedowns and Impairment of $354,000.
- Across earlier years, Asset Writedowns and Impairment came in at $32,000 in FY2023 and -$8,000 in FY2021.
- The Q4 2024 figure is the lowest quarterly Asset Writedowns and Impairment since Q1 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn |
| 10 | Valion Bio | 339,352.00 | -19.10 Mn | - |
API Access
Valion Bio Asset Writedowns and Impairment API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=VBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "asset-writedowns-and-impairment", "ticker": "VBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=VBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();